RxDoctor Payments Data

Michael Weiss, MD

Family Medicine · Columbus, OHNPI 1154350684

Payments from drug & device makers

$17,041in general payments, 2019–2025

Across 782 payments — averaging $21.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • Bristol Myers Squibb$2K
  • Viiv Healthcare Company$1K
  • AstraZeneca$1K
  • Amgen$920
  • Gilead$724
  • plus $7K from 51 others

What the payments were for

  • Food & beverage$11,89298%
  • Education$2092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)144$4,338
Bristol Myers Squibb1$2,152
Viiv Healthcare Company70$1,398
AstraZeneca61$1,006
Amgen(2 entities)70$920
Gilead30$724
Lilly USA, LLC33$517
Novo Nordisk35$442
Merck34$414
Boehringer Ingelheim21$366
Johnson & Johnson(2 entities)27$365
Pfizer19$352
GSK25$306
Bayer13$275
Takeda Pharmaceuticals U.S.A., Inc.18$275
Biohaven Pharmaceuticals, Inc.13$271
Axsome Therapeutics, Inc.11$234
Astellas Pharma US Inc11$196
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$172
Teva Pharmaceuticals USA, Inc.8$145
Antares Pharma, Inc.8$141
Biohaven Pharmaceutical Holding Company Ltd.13$132
Novartis8$129
E.r. Squibb & Sons, L.L.C.7$128
Otsuka America Pharmaceutical, Inc.6$125
Corium, LLC9$125
Exact Sciences6$116
Abbott6$105
Janssen Products, LP1$100
Amarin Pharma, Inc.6$90
Supernus Pharmaceuticals, Inc.4$77
Esperion Therapeutics, Inc.5$76
Theratechnologies Inc.3$71
Sanofi-aventis U.S. LLC4$66
Phathom Pharmaceuticals, Inc.3$65
Bausch Health US, LLC4$65
Mayne Pharma Commercial LLC3$63
Kowa Pharmaceuticals America, Inc.4$60
Tolmar, Inc.3$51
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$36
Lundbeck LLC2$33
Circassia Inc.2$32
Arbor Pharmaceuticals, Inc.2$30
Idorsia Pharmaceuticals US Inc2$29
Tris Pharma Inc2$26
Jazz Pharmaceuticals Inc.1$24
Lucid Diagnostics Inc.1$23
Endo Pharmaceuticals Inc.1$20
Aytu Biopharma, Inc.1$18
Nestle Healthcare Nutrition Inc.1$18
Shield Therapeutics Inc1$17
Clarus Therapeutics Inc.1$17
Amneal Pharmaceuticals LLC1$15
Shire North American Group Inc1$14
Genentech USA, Inc.1$13
Adlon Therapeutics L.p.1$12
Organon1$10

How this compares

$17,041 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$156,323
Medicare patients
381
Services billed
1,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
DovatoDolutegravir Sodium/Lamivudine92$261,865
EliquisApixaban153$153,703
MounjaroTirzepatide124$143,819
JardianceEmpagliflozin125$115,518
TriumeqAbacavir/Dolutegravir/Lamivudi29$109,233
FarxigaDapagliflozin Propanediol85$97,920
PrezcobixDarunavir/Cobicistat38$91,402
OzempicSemaglutide65$75,249
Trelegy ElliptaFluticasone/Umeclidin/Vilanter72$61,194
TivicayDolutegravir Sodium25$56,306
GenvoyaElviteg/Cob/Emtri/Tenof Alafen12$48,022
JanuviaSitagliptin Phosphate43$40,285
TrulicityDulaglutide22$38,952
DescovyEmtricitabine/Tenofov Alafenam17$37,131
DelstrigoDoravirine/Lamivu/Tenofov Diso12$36,918

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Viiv Healthcare CompanyDovato, Triumeq, Tivicay, Juluca$1,398$456,398158 claims
Lilly USA, LLCMounjaro, Trulicity$517$182,771146 claims
PfizerEliquis, Nurtec Odt$352$167,463167 claims
Johnson & JohnsonPrezcobix, Xarelto$365$127,35174 claims
AstraZenecaFarxiga, Breztri Aerosphere, Nexium$1,006$123,304124 claims
Boehringer IngelheimJardiance$366$115,518125 claims
MerckJanuvia, Delstrigo, Isentress$414$101,49868 claims
GileadGenvoya, Descovy$724$85,15429 claims
Novo NordiskOzempic$442$75,24965 claims
GSKTrelegy Ellipta, Anoro Ellipta$306$66,79784 claims
AmgenProlia$920$31,37618 claims
AbbVieLinzess, Synthroid$4,338$29,049111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →